BackIO Biotech Overview

IO Biotech Net Tangible Assets

IO Biotech's net tangible assets is $910K.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$911000.00
↓ 98.74% YoYΔ $-71.65M vs prior year quarter

Peer average / median

Loading

IO Biotech Net Tangible Assets History

Loading

IO Biotech vs. peers: Net Tangible Assets Comparison

Loading

IO Biotech Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

IO Biotech (IOBT) FAQ

As of the most recent data (September 2025), IOBT shows a net tangible assets of $910K. That compares with $73M in the prior-year period — down 98.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IOBT's net tangible assets is now $910K (was $73M) — a 98.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether IO Biotech is outperforming or lagging.

Tracking IOBT's net tangible assets over time shows whether IO Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $910K That compares with $73M in the prior-year period — down 98.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has IO Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $910K) with ownership activity and broader fundamentals.